We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Method for Treating Sepsis

By HospiMedica International staff writers
Posted on 14 May 2012
A novel method for treating sepsis is based on margination, a natural phenomenon where bacteria and leukocytes move toward the endothelial lining of blood vessel walls.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) and the National University of Singapore have designed a branchlike system of microfluidic channels (20 µm high by 20 µm wide) etched onto a polymer chip, which mimic the marginizing action of vessels on bacteria and inflammatory cellular components such as leukocytes and platelets, in order to separate them from red blood cells (RBCs). More...
By using a simple cascaded channel design, the blood also undergoes a two-stage bacteria removal in a single pass through the device, thereby allowing higher bacterial removal efficiency.

“The developed technique offers significant advantages including high throughput and label-free separation, which allows nonspecific removal of any blood-borne pathogens,” concluded Han Wei Hou, PhD, of the MIT department of electrical engineering and computer science. “The continuous processing and collection mode could potentially enable the return of filtered blood back to the patient directly, similar to a simple and complete dialysis circuit setup.”
In an experiment with the prototype device, the researchers demonstrated highly efficient removal of the bacteria Escherichia coli (80%) and the yeast Saccharomyces cerevisiae (90%), as well as a greater than 80% depletion of inflammatory cellular components. The researchers also designed and tested a larger blood cleansing system, consisting of six microfluidic channel networks in parallel. They are also conducting a small-scale animal test to validate the efficacy of the technique in vivo.

Related Links:

Massachusetts Institute of Technology


National University of Singapore



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tourniquet System
heidi– mein Tourniquet
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.